BamSEC and AlphaSense Join Forces
Learn More

Cidara Therapeutics Inc.

NASDAQ: CDTX    
Share price (8/14/25): $63.55    
Market cap (8/14/25): $1.612 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 50 pages Cidara Therapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: May 22, 2024 Approved by the Stockholders: July 18, 2024 Amended by the Board of Directors: March 14, 2025 Approved by the Stockholders: June 18, 2025
12/34/56
EX-10.5
from 10-Q 39 pages Open Market Sale Agreementsm1
12/34/56
EX-10.4
from 10-Q 10 pages April 25, 2025 [By Email] Nicole Davarpanah, M.D., J.D. 14403 Marine Drive Silver Spring, MD 20905 Re: Employment Agreement Dear Nicole
12/34/56
EX-10.30
from 10-K 9 pages February 7, 2025 by Email Frank Karbe Mill Valley, Ca
12/34/56
EX-10.7
from 10-K 26 pages Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan Adopted by the Board of Directors: December 4, 2020 Amended by the Compensation Committee of the Board of Directors: August 16, 2021 Amended by the Compensation and Human Capital Committee of the Board of Directors: July 18, 2024 Amended by the Compensation and Human Capital Committee of the Board of Directors: February 12, 2025
12/34/56
EX-10.5
from 10-K 2 pages Cidara Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy Approved by Board of Directors: December 6, 2024
12/34/56
EX-10.1
from 8-K 8 pages February 14, 2025 Preetam Shah, Phd, Mba via Email/Docusign Dear Preetam: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Cidara Therapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Last Day of Work With the Company and Your Employment Termination Date Will Be February 24, 2025 (The “Separation Date”)
12/34/56
EX-10.1
from 8-K 17 pages January 7, 2025 Taylor Sandison 1042 3rd Street, Encinitas, Ca 92024 TGSAND@UW.EDU via Email/Docusign Dear Taylor: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Cidara Therapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1.separation. Your Last Day of Work With the Company and Your Employment Termination Date Will Be February 3, 2025 (The “Separation Date”)
12/34/56
EX-10.2
from 8-K 30 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 54 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 10-Q 55 pages License and Technology Transfer Agreement Between Cidara Therapeutics, Inc. and Janssen Pharmaceuticals, Inc. April 23, 2024
12/34/56
EX-10.3
from 10-Q 26 pages Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan Adopted by the Board of Directors: December 4, 2020 Amended by the Compensation Committee of the Board of Directors: August 16, 2021 Amended by the Compensation and Human Capital Committee of the Board of Directors: July 18, 2024
12/34/56
EX-10.1
from 8-K 49 pages Cidara Therapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: May 22, 2024 Approved by the Stockholders: July 18, 2024
12/34/56
EX-10.2
from 8-K 5 pages Support Agreement
12/34/56
EX-10.1
from 8-K 61 pages Securities Purchase Agreement
12/34/56
EX-10.5
from 10-K 2 pages Cidara Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy Approved by Board of Directors: December 4, 2023
12/34/56
EX-10.1
from 10-Q 1 page Seventh Amendment to Lease Dated April 20, 2023
12/34/56
EX-10.5
from 10-K 2 pages Cidara Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy Approved by Board of Directors: December 5, 2022
12/34/56
EX-10.4
from 10-Q 8 pages August 19, 2021 by Email Re: Employment Agreement Dear Preetam
12/34/56
EX-10.3
from 10-Q 8 pages August 17, 2021 by Email
12/34/56